BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56.
Stay updated with breaking news from Call Transcript March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56.
Operator: Hello, and welcome, everyone, to the Second Quarter Fiscal 2024 Earnings Call for CMC.
Operator: Good morning, ladies and gentlemen. My name is Abby, and I will be your conference operator today.
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Lufax Holding Limited Fourth Quarter 2023 Earnings Call. [Operator Instructions].
Iris Eveleigh: Good morning, everyone. Dear analysts, the investors, a warm welcome from my side to our Full Year 2023 Results Call. I'm here with Leo and Marc, who will present our results to you.